Acadia Healthcare price target lowered to $43 from $64 at RBC Capital

RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $43 from $64 and keeps an Outperform rating on the shares after its Q4 earnings miss. The stock fell off on Friday followed weaker than expected 2025 guidance, with an EBITDA range below the firm’s Street-low estimate, as well as a revised multi-year outlook suggesting a notable reset of intermediate-term margin expectations, the analyst tells investors in a research note. The firm remains at Outperform on “atypically depressed” valuation, but also “feels less inclined” at this point to demand a premium to historical acute care hospital multiples, RBC added.